Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 51-57

  Di Giovanni, Giuseppe ^a   Di Mascio, Michele ^a   Di Matteo, Vincenzo ^a   Esposito, Ennio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; DOPAMINE 3 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; ELECTRIC ACTIVITY; ELECTROPHYSIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIMBIC SYSTEM; MESENCEPHALON; MICROIONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SUBSTANTIA NIGRA;

ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SUBSTANTIA NIGRA; SULPIRIDE; VENTRAL TEGMENTAL AREA;

EID: 0032454971     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Beckman B, Hippius H and Rüther E (1979) Treatment of schizophrenia. Progr Neuro-Psychopharmacol 3:47-52.
2. 2 receptors with specific cellular elements in the basal ganglia of the cat: The uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Neuroscience 27:851-863.
3. Belmaker RH and Wald D (1977) Haloperidol in normals. Br J Psychiatry 131:222-223.
4. 2 receptor mRNA. Brain Res 564:203-219.
5. Boyer P and Lecrubier Y (1996) Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine. Eur Psychiatry 11:suppl 3, 135s-140s.
6. Boyer P, Lecrubier Y, Puech AJ, Dewailly J and Aubin F (1995) Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 166:68-72.
7. Bunney BS and Aghajanian GK (1976) d-Amphetamine-induced inhibition of central dopaminergic neurons: Mediation by a striato-nigral feedback pathway. Science 192:391-393.
8. Bunney BS and Grace AA (1978) Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1728.
9. Bunney BS, Sesack SR and Silva NL (1987) Midbrain dopaminergic systems: Neurophysiology and electrophysiological pharmacology. In Psychopharmacology: A Third Generation of Progress (Meltzer HY, ed), pp 113-126, Raven Press, New York.
10. Bunney BS, Walters JR, Roth RH and Aghajanian GK (1973) Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560-571.
11. Chiodo LA and Bunney BS (1984) Effects of dopamine antagonists on midbrain dopamine cell activity. In Catecholamines: Neuropharmacology and Central Nervous System: Theoretical Aspects (Usdin E, Carlsson A, Dahlstrom A and Engel J, eds), pp 369-391, Alan R. Liss, New York.
12. Chiodo LA and Bunney BS (1983) Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619.
13. Crane GE (1973) Persistent dyskinesia. Br J Psychiatry 122:395-405.
14. Crow TJ, Cross AJ, Johnstone EC, Longden A, Owen F and Ridley RM (1980) Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication. Adv Biochem Psychopharmacol 24:495-503.
15. Delcker A, Schoon ML, Oczkowski B and Gaertener HJ (1990) Amisulpride versus haloperidol in the treatment of schizophrenic patients: Results of a double-blind study. Pharmacopsychiatry 23:125-130.
16. de Sousa MP (1996) Amisulpiride in dysthymia: results of a naturalistic study in general practice. Eur Psychiatry 11: suppl 3, 145s-147s.
17. Deutch AY, Moghaddam B, Innis R, Krystal JH, Aghajanian GK, Bunney BS and Charney DS (1991) Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121-156.
18. Gonon, FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19-28.
19. Grace AA and Bunney BS (1980) Nigral dopamine neurons: Intracellular recording and identification with L-DOPA injection combined with fluorescence histochemistry. Science 210:654-656.
20. Grace AA and Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890.
21. Grace AA and Bunney BS (1986) Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092-1100.
22. Grace AA, Bunney BS, Moore H and Todd CL (1997) Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci 20:31-37.
23. Hökfelt T, Ljiungdhal A, Fuxe K and Johansson O (1974) Dopamine nerve terminals in the limbic cortex: Aspects of the dopamine hypothesis of schizophrenia. Science 184:177-179.
24. Kelland MD, Freeman AS and Chiodo LA (1989) Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration. Synapse 3:30-37.
25. Klawans HL (1976) Therapeutic approaches to neuroleptic-induced tardive dyskinesia. In The Basal Ganglia (Yahr MD, ed), pp 447-457, Raven Press, New York.
26. Klein DF, Gittelman R, Quitkin F and Rifkin A (1980) Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children, ed. 2. Williams & Wilkins, Baltimore.
27. 2 receptors to increase potassium conductance in neurons of the rat substantia nigra zona compacta. J Physiol (Lond) 392:397-416.
28. 3 autoreceptors inhibits firing of ventral tegmental area neurones in vivo. Eur J Pharmacol 275:R7-R9.
29. 3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252.
30. Matthysse S (1973) Antipsychotic drug actions: A clue to the neuropathology of schizophrenia? Fed Proc 32:200-205.
31. Mereu G, Collu M, Ongini E, Biggio G and Gessa GL (1985) SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine. Eur J Pharmacol 111:393-396.
32. 125]SCH 23982 in adjacent brain sections. Neuroscience 27:865-870.
33. Murase S, Grenhoff J, Chouvet G, Gonon FG and Svensson TH (1993) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 157:53-56.
34. Overton PG, Tong Z-Y and Clark D (1996) A pharmacological analysis of the burst events induced in midbrain dopaminergic neurons by electrical stimulation of the prefrontal cortex in the rat. J Neural Transm 103:523-540.
35. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
36. 3 dopamine receptor antagonistic activity and limbic selectivity. J Pharmacol Exp Ther 280:73-82.
37. Pucak ML and Grace AA (1994) Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther 271:1181-1192.
38. 3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280:83-97.
39. Skirboll LR, Grace AA and Bunney BS (1979) Dopamine auto- and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206:80-82.
40. Smeraldi E, Haefele E, Crespi G, Casadei GL, Biondi F and Vigorelli E (1996) Amisulpiride versus fluoxetine in dysthymia: Preliminary results of a double-blind comparative study. Eur Psychiatry 11: suppl 3, 141s-143s.
41. Seeman P (1990) Atypical neuroleptics: role of multiple receptors, endogenous dopamine and receptor linkage. Acta Psychiatr Scand 82: suppl 358, 14-20.
42. 2 receptor. Eur J Pharmacol 225:331-337.
43. 3) as a target for neuroleptics. Nature 347:146-151.
44. Stevens JR (1973) An anatomy of schizophrenia? Arch Gen Psychiatry 29:177-189.
45. Tong Z-Y, Overton PG and Clark D (1996) Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events. Synapse 22:195-208.
46. Walters JR, Bunney BS and Roth RH (1975) Piribedil and apomorphine: Pre- and postsynaptic effects on dopamine synthesis and neuronal activity. Adv Neurol 9:273-284.
47. Waters N, Hansson L, Löfberg L and Carlsson A (1994) Intracerebral infusion of (+)-AJ76 and (+)-UH232: Effects on dopamine release and metabolism in vivo. Eur J Pharmacol 251:181-190.
48. White FJ (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19:405-436.
49. White FJ and Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054-1057.
50. White FJ and Wang RY (1984) Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: Microiontophoretic studies. J Pharmacol Exp Ther 231:275-280.